| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C20H26N4O4 |
| Molar mass | 386.452 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Bevenopran (INN,USAN) (former developmental code namesCB-5945,ADL-5945,MK-2402,OpRA III) is aperipherally acting μ-opioid receptor antagonist that also acts onδ-opioid receptors and was under development byCubist Pharmaceuticals for the treatment of chronicopioid-inducedconstipation.[1][2][3] It reachedphase IIIclinical trials for this indication before being discontinued.[4][5]
Thisdrug article relating to thegastrointestinal system is astub. You can help Wikipedia byadding missing information. |